Switch to:
GuruFocus has detected 5 Warning Signs with Teva Pharmaceutical Industries Ltd $TEVA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Capital Expenditure
$-931 Mil (TTM As of Mar. 2017)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Teva Pharmaceutical Industries Ltd's cash flow for capital expenditures for the three months ended in Mar. 2017 was $-202 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2017 was $-931 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Teva Pharmaceutical Industries Ltd Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2017 was -175 (Jun. 2016 ) + -221 (Sep. 2016 ) + -333 (Dec. 2016 ) + -202 (Mar. 2017 ) = $-931 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Cash Flow_CPEX -542-681-719-710-1,053-1,104-1,031-929-772-901

Teva Pharmaceutical Industries Ltd Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
Cash Flow_CPEX -300-185-169-170-248-172-175-221-333-202
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK